{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:23:02Z","timestamp":1775136182574,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T00:00:00Z","timestamp":1716422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Science and Technology Project of Guangzhou","award":["2023A04J1856"],"award-info":[{"award-number":["2023A04J1856"]}]},{"name":"The Science and Technology Project of Guangzhou","award":["2023A03J0779"],"award-info":[{"award-number":["2023A03J0779"]}]},{"name":"College Students' innovation and Entrepreneurship Competition of Guangzhou University of Chinese Medicine","award":["202210572184"],"award-info":[{"award-number":["202210572184"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12033-024-01185-8","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T12:01:41Z","timestamp":1716465701000},"page":"2085-2097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sophoraflavanone G Inhibits RANKL-Induced Osteoclastogenesis via MAPK\/NF-\u03baB Signaling Pathway"],"prefix":"10.1007","volume":"67","author":[{"given":"Xinchun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhida","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6700-4409","authenticated-orcid":false,"given":"Jian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,23]]},"reference":[{"key":"1185_CR1","first-page":"391","volume":"51","author":"E Czerwinski","year":"1994","unstructured":"Czerwinski, E. (1994). Diagnosis of osteoporosis. Przeglad Lekarski, 51, 391\u2013397.","journal-title":"Przeglad Lekarski"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari, N., et al. (2021). The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 16, 609. https:\/\/doi.org\/10.1186\/s13018-021-02772-0","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","volume":"17","author":"CL Gregson","year":"2022","unstructured":"Gregson, C. L., et al. (2022). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 17, 58. https:\/\/doi.org\/10.1007\/s11657-022-01061-5","journal-title":"Archives of Osteoporosis"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.11138\/ccmbm\/2015.12.2.151","volume":"12","author":"G Marcucci","year":"2015","unstructured":"Marcucci, G., & Brandi, M. L. (2015). Rare causes of osteoporosis. Clinical Cases in Mineral and Bone Metabolism, 12, 151\u2013156. https:\/\/doi.org\/10.11138\/ccmbm\/2015.12.2.151","journal-title":"Clinical Cases in Mineral and Bone Metabolism"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis, J. A., et al. (2021). SCOPE 2021: A new scorecard for osteoporosis in Europe. Archives of Osteoporosis, 16, 82. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","journal-title":"Archives of Osteoporosis"},{"key":"1185_CR6","unstructured":"Rosen, C. J (2000). in Endotext (eds K. R. Feingold et al.)."},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00441-010-1086-1","volume":"343","author":"A Neve","year":"2011","unstructured":"Neve, A., Corrado, A., & Cantatore, F. P. (2011). Osteoblast physiology in normal and pathological conditions. Cell and Tissue Research, 343, 289\u2013302. https:\/\/doi.org\/10.1007\/s00441-010-1086-1","journal-title":"Cell and Tissue Research"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1007\/s11033-021-06288-y","volume":"48","author":"S Berardi","year":"2021","unstructured":"Berardi, S., Corrado, A., Maruotti, N., Cici, D., & Cantatore, F. P. (2021). Osteoblast role in the pathogenesis of rheumatoid arthritis. Molecular Biology Reports, 48, 2843\u20132852. https:\/\/doi.org\/10.1007\/s11033-021-06288-y","journal-title":"Molecular Biology Reports"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00418-018-1636-2","volume":"149","author":"T Ono","year":"2018","unstructured":"Ono, T., & Nakashima, T. (2018). Recent advances in osteoclast biology. Histochemistry and Cell Biology, 149, 325\u2013341. https:\/\/doi.org\/10.1007\/s00418-018-1636-2","journal-title":"Histochemistry and Cell Biology"},{"issue":"20","key":"1185_CR10","doi-asserted-by":"publisher","first-page":"7717","DOI":"10.3390\/ijms21207717","volume":"21","author":"K Soe","year":"2020","unstructured":"Soe, K. (2020). Osteoclast fusion: Physiological regulation of multinucleation through heterogeneity-potential implications for drug sensitivity. International Journal of Molecular Sciences, 21(20), 7717.","journal-title":"International Journal of Molecular Sciences"},{"key":"1185_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.988365","volume":"14","author":"VC Brom","year":"2023","unstructured":"Brom, V. C., et al. (2023). Agonistic and antagonistic targeting of immune checkpoint molecules differentially regulate osteoclastogenesis. Frontiers in Immunology, 14, 988365. https:\/\/doi.org\/10.3389\/fimmu.2023.988365","journal-title":"Frontiers in Immunology"},{"key":"1185_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.892229","volume":"10","author":"R Hua","year":"2022","unstructured":"Hua, R., Gu, S., & Jiang, J. X. (2022). Connexin 43 hemichannels regulate osteoblast to osteocyte differentiation. Frontiers in Cell and Developmental Biology, 10, 892229. https:\/\/doi.org\/10.3389\/fcell.2022.892229","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjmed.2012.06.023","volume":"126","author":"M McClung","year":"2013","unstructured":"McClung, M., et al. (2013). Bisphosphonate therapy for osteoporosis: Benefits, risks, and drug holiday. American Journal of Medicine, 126, 13\u201320. https:\/\/doi.org\/10.1016\/j.amjmed.2012.06.023","journal-title":"American Journal of Medicine"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"e220334","DOI":"10.20945\/2359-4292-2022-0334","volume":"68","author":"B Gehrke","year":"2023","unstructured":"Gehrke, B., Alves Coelho, M. C., Brasil d\u2019Alva, C., & Madeira, M. (2023). Long-term consequences of osteoporosis therapy with bisphosphonates. Archives of Endocrinology Metabolism, 68, e220334. https:\/\/doi.org\/10.20945\/2359-4292-2022-0334","journal-title":"Archives of Endocrinology Metabolism"},{"key":"1185_CR15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179942","author":"T Bellido","year":"2024","unstructured":"Bellido, T. (2024). Bisphosphonates for osteoporosis: from bench to clinic. The Journal of Clinical Investigation. https:\/\/doi.org\/10.1172\/JCI179942","journal-title":"The Journal of Clinical Investigation"},{"key":"1185_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s00198-010-1326-y","volume":"22","author":"S Ferrari-Lacraz","year":"2011","unstructured":"Ferrari-Lacraz, S., & Ferrari, S. (2011). Do RANKL inhibitors (denosumab) affect inflammation and immunity? Osteoporosis International, 22, 435\u2013446. https:\/\/doi.org\/10.1007\/s00198-010-1326-y","journal-title":"Osteoporosis International"},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12325-021-01936-y","volume":"39","author":"DL Kendler","year":"2022","unstructured":"Kendler, D. L., Cosman, F., Stad, R. K., & Ferrari, S. (2022). Denosumab in the treatment of osteoporosis: 10 years later: A narrative review. Advances in Therapy, 39, 58\u201374. https:\/\/doi.org\/10.1007\/s12325-021-01936-y","journal-title":"Advances in Therapy"},{"key":"1185_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10539","volume":"5","author":"MM McDonald","year":"2021","unstructured":"McDonald, M. M., Kim, A. S., Mulholland, B. S., & Rauner, M. (2021). New insights into osteoclast biology. Journal of Bone and Mineral Research Plus, 5, e10539. https:\/\/doi.org\/10.1002\/jbm4.10539","journal-title":"Journal of Bone and Mineral Research Plus"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.bcp.2013.08.009","volume":"86","author":"BH Kim","year":"2013","unstructured":"Kim, B. H., et al. (2013). Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs. Biochemical Pharmacology, 86, 950\u2013959. https:\/\/doi.org\/10.1016\/j.bcp.2013.08.009","journal-title":"Biochemical Pharmacology"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/ddr.21938","volume":"83","author":"W Cheng","year":"2022","unstructured":"Cheng, W., Liu, D., Guo, M., Li, H., & Wang, Q. (2022). Sophoraflavanone G suppresses the progression of triple-negative breast cancer via the inactivation of EGFR-PI3K-AKT signaling. Drug Development Research, 83, 1138\u20131151. https:\/\/doi.org\/10.1002\/ddr.21938","journal-title":"Drug Development Research"},{"key":"1185_CR21","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/ptr.6675","volume":"34","author":"H Wang","year":"2020","unstructured":"Wang, H., Tong, Y., Xiao, D., & Xia, B. (2020). Involvement of mTOR-related signaling in antidepressant effects of Sophoraflavanone G on chronically stressed mice. Phytotherapy Research, 34, 2246\u20132257. https:\/\/doi.org\/10.1002\/ptr.6675","journal-title":"Phytotherapy Research"},{"key":"1185_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23116104","author":"MC Wang","year":"2022","unstructured":"Wang, M. C., et al. (2022). Sophoraflavanone G from Sophora flavescens ameliorates allergic airway inflammation by suppressing Th2 response and oxidative stress in a murine asthma model. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms23116104","journal-title":"International Journal of Molecular Sciences"},{"key":"1185_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2019.06.007","volume":"136","author":"Z Yang","year":"2019","unstructured":"Yang, Z., et al. (2019). Solid self-microemulsifying drug delivery system of Sophoraflavanone G: Prescription optimization and pharmacokinetic evaluation. European Journal of Pharmaceutical Sciences, 136, 104953. https:\/\/doi.org\/10.1016\/j.ejps.2019.06.007","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"1185_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122116","author":"ZC Qiu","year":"2016","unstructured":"Qiu, Z. C., et al. (2016). Discovery of a new class of Cathepsin K inhibitors in rhizoma drynariae as potential candidates for the treatment of osteoporosis. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms17122116","journal-title":"International Journal of Molecular Sciences"},{"key":"1185_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1015693","author":"W Deng","year":"2022","unstructured":"Deng, W., et al. (2022). Dehydromiltirone inhibits osteoclast differentiation in RAW2647 and bone marrow macrophages by modulating MAPK and NF-kappaB activity. Frontiers in Pharmacology. https:\/\/doi.org\/10.3389\/fphar.2022.1015693","journal-title":"Frontiers in Pharmacology"},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1302\/2046-3758.114.BJR-2020-0308.R2","volume":"11","author":"YD Liu","year":"2022","unstructured":"Liu, Y. D., Liu, J. F., & Liu, B. (2022). N, N-Dimethylformamide inhibits high glucose-induced osteoporosis via attenuating MAPK and NF-kappaB signalling. Bone Joint Research, 11, 200\u2013209. https:\/\/doi.org\/10.1302\/2046-3758.114.BJR-2020-0308.R2","journal-title":"Bone Joint Research"},{"key":"1185_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2021-068033","volume":"381","author":"MN Handel","year":"2023","unstructured":"Handel, M. N., et al. (2023). Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: Systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials. BMJ, 381, e068033. https:\/\/doi.org\/10.1136\/bmj-2021-068033","journal-title":"BMJ"},{"key":"1185_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"JA Kanis","year":"2019","unstructured":"Kanis, J. A., et al. (2019). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporosis International, 30, 3\u201344. https:\/\/doi.org\/10.1007\/s00198-018-4704-5","journal-title":"Osteoporosis International"},{"key":"1185_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092073","author":"JM Kim","year":"2020","unstructured":"Kim, J. M., Lin, C., Stavre, Z., Greenblatt, M. B., & Shim, J. H. (2020). Osteoblast-osteoclast communication and bone homeostasis. Cells. https:\/\/doi.org\/10.3390\/cells9092073","journal-title":"Cells"},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"116641","DOI":"10.1016\/j.jep.2023.116641","volume":"315","author":"S Paramasivam","year":"2023","unstructured":"Paramasivam, S., & Perumal, S. S. (2023). Methanolic extract of O.umbellata L. exhibits anti-osteoporotic effect via promoting osteoblast proliferation in MG-63 cells and inhibiting osteoclastogenesis in RANKL-stimulated RAW 264.7 cells. Journal of Ethnopharmacology, 315, 116641. https:\/\/doi.org\/10.1016\/j.jep.2023.116641","journal-title":"Journal of Ethnopharmacology"},{"key":"1185_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells11010132","author":"Z Yao","year":"2021","unstructured":"Yao, Z., Getting, S. J., & Locke, I. C. (2021). Regulation of TNF-induced osteoclast differentiation. Cells. https:\/\/doi.org\/10.3390\/cells11010132","journal-title":"Cells"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen, S., et al. (2023). Macrophages in immunoregulation and therapeutics. Signal Transduction and Targeted Therapy, 8, 207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","volume":"24","author":"S Fujioka","year":"2004","unstructured":"Fujioka, S., et al. (2004). NF-kappaB and AP-1 connection: Mechanism of NF-kappaB-dependent regulation of AP-1 activity. Molecular and Cellular Biology, 24, 7806\u20137819. https:\/\/doi.org\/10.1128\/MCB.24.17.7806-7819.2004","journal-title":"Molecular and Cellular Biology"},{"key":"1185_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.818462","volume":"10","author":"N Zou","year":"2022","unstructured":"Zou, N., Liu, R., & Li, C. (2022). Cathepsin K(+) Non-osteoclast cells in the skeletal system: Function, models, identity, and therapeutic implications. Frontiers in Cell and Developmental Biology, 10, 818462. https:\/\/doi.org\/10.3389\/fcell.2022.818462","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1172\/JCI64840","volume":"123","author":"S Lotinun","year":"2013","unstructured":"Lotinun, S., et al. (2013). Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation. The Journal of Clinical Investigation, 123, 666\u2013681. https:\/\/doi.org\/10.1172\/JCI64840","journal-title":"The Journal of Clinical Investigation"},{"key":"1185_CR36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00223-020-00666-7","volume":"106","author":"Y Xin","year":"2020","unstructured":"Xin, Y., et al. (2020). New function of RUNX2 in regulating osteoclast differentiation via the AKT\/NFATc1\/CTSK axis. Calcified Tissue International, 106, 553\u2013566. https:\/\/doi.org\/10.1007\/s00223-020-00666-7","journal-title":"Calcified Tissue International"},{"key":"1185_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang, L., & Karin, M. (2001). Mammalian MAP kinase signalling cascades. Nature, 410, 37\u201340. https:\/\/doi.org\/10.1038\/35065000","journal-title":"Nature"},{"key":"1185_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.688","volume":"12","author":"W Dong","year":"2022","unstructured":"Dong, W., et al. (2022). Myocardin-related transcription factor A drives ROS-fueled expansion of hepatic stellate cells by regulating p38-MAPK signalling. Clinical and Translational Medicine, 12, e688. https:\/\/doi.org\/10.1002\/ctm2.688","journal-title":"Clinical and Translational Medicine"},{"key":"1185_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103004","author":"K Lee","year":"2018","unstructured":"Lee, K., Seo, I., Choi, M. H., & Jeong, D. (2018). Roles of mitogen-activated protein kinases in osteoclast biology. International Journal of Molecular Science. https:\/\/doi.org\/10.3390\/ijms19103004","journal-title":"International Journal of Molecular Science"},{"key":"1185_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024780","volume":"6","author":"Y He","year":"2011","unstructured":"He, Y., et al. (2011). Erk1 positively regulates osteoclast differentiation and bone resorptive activity. PLoS ONE, 6, e24780. https:\/\/doi.org\/10.1371\/journal.pone.0024780","journal-title":"PLoS ONE"},{"issue":"5","key":"1185_CR41","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.4049\/jimmunol.0804314","volume":"183","author":"MS Lee","year":"2009","unstructured":"Lee, M. S., et al. (2009). GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras\/ERK pathway. The Journal of Immunology, 183(5), 3390\u20133399.","journal-title":"The Journal of Immunology"},{"key":"1185_CR42","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/s1097-2765(01)00360-4","volume":"8","author":"KN Weilbaecher","year":"2001","unstructured":"Weilbaecher, K. N., et al. (2001). Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi\/mi) mice. Molecular Cell, 8, 749\u2013758. https:\/\/doi.org\/10.1016\/s1097-2765(01)00360-4","journal-title":"Molecular Cell"},{"key":"1185_CR43","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1242\/jcs.00082","volume":"115","author":"JP David","year":"2002","unstructured":"David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H., & Wagner, E. F. (2002). JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and-independent mechanisms. Journal of Cell Science, 115, 4317\u20134325. https:\/\/doi.org\/10.1242\/jcs.00082","journal-title":"Journal of Cell Science"},{"key":"1185_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1359\/jbmr.080211","volume":"23","author":"F Ikeda","year":"2008","unstructured":"Ikeda, F., et al. (2008). JNK\/c-Jun signaling mediates an anti-apoptotic effect of RANKL in osteoclasts. Journal of Bone and Mineral Research, 23, 907\u2013914. https:\/\/doi.org\/10.1359\/jbmr.080211","journal-title":"Journal of Bone and Mineral Research"},{"key":"1185_CR45","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1242\/jcs.028217","volume":"121","author":"EJ Chang","year":"2008","unstructured":"Chang, E. J., et al. (2008). The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. Journal of Cell Science, 121, 2555\u20132564. https:\/\/doi.org\/10.1242\/jcs.028217","journal-title":"Journal of Cell Science"},{"key":"1185_CR46","doi-asserted-by":"publisher","first-page":"45964","DOI":"10.1038\/srep45964","volume":"7","author":"Q Cong","year":"2017","unstructured":"Cong, Q., et al. (2017). p38alpha MAPK regulates proliferation and differentiation of osteoclast progenitors and bone remodeling in an aging-dependent manner. Science and Reports, 7, 45964. https:\/\/doi.org\/10.1038\/srep45964","journal-title":"Science and Reports"},{"key":"1185_CR47","doi-asserted-by":"publisher","first-page":"31155","DOI":"10.1074\/jbc.M001229200","volume":"275","author":"M Matsumoto","year":"2000","unstructured":"Matsumoto, M., Sudo, T., Saito, T., Osada, H., & Tsujimoto, M. (2000). Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). Journal of Biological Chemistry, 275, 31155\u201331161. https:\/\/doi.org\/10.1074\/jbc.M001229200","journal-title":"Journal of Biological Chemistry"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01185-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01185-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T01:02:57Z","timestamp":1744246977000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01185-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,23]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01185-8","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,23]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were adopted by the Guangzhou University of Chinese Medicine Animal Ethics Committee (Number: 20231009001).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}